JO3545B1 - Carrier-antibody compositions and methods of making and using the same - Google Patents

Carrier-antibody compositions and methods of making and using the same

Info

Publication number
JO3545B1
JO3545B1 JOP/2016/0048A JOP20160048A JO3545B1 JO 3545 B1 JO3545 B1 JO 3545B1 JO P20160048 A JOP20160048 A JO P20160048A JO 3545 B1 JO3545 B1 JO 3545B1
Authority
JO
Jordan
Prior art keywords
making
methods
same
carrier
antibody compositions
Prior art date
Application number
JOP/2016/0048A
Other languages
Arabic (ar)
Inventor
Wendy K Nevala
Svetomir N Markovic
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Priority to JOP/2016/0048A priority Critical patent/JO3545B1/en
Application granted granted Critical
Publication of JO3545B1 publication Critical patent/JO3545B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
JOP/2016/0048A 2016-03-22 2016-03-22 Carrier-antibody compositions and methods of making and using the same JO3545B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2016/0048A JO3545B1 (en) 2016-03-22 2016-03-22 Carrier-antibody compositions and methods of making and using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2016/0048A JO3545B1 (en) 2016-03-22 2016-03-22 Carrier-antibody compositions and methods of making and using the same

Publications (1)

Publication Number Publication Date
JO3545B1 true JO3545B1 (en) 2020-07-05

Family

ID=75468993

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2016/0048A JO3545B1 (en) 2016-03-22 2016-03-22 Carrier-antibody compositions and methods of making and using the same

Country Status (1)

Country Link
JO (1) JO3545B1 (en)

Similar Documents

Publication Publication Date Title
PH12017500022A1 (en) Carrier-antibody compositions and methods of making and using the same
MX2024008677A (en) Camptothecin conjugates.
MX2022011818A (en) Methods and compositions for targeting t-cell cancers.
MX2019007021A (en) Il-11ra antibodies.
MX2021006235A (en) Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof.
AU2018236742B2 (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
MX2019007020A (en) Il-11 antibodies.
PH12018500380A1 (en) Anti-dll3 antibody drug conjugates and methods of use
PH12018502478A1 (en) Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
ZA201708265B (en) Tigit-binding agents and uses thereof
PH12016501680B1 (en) Anti-egfrviii antibodies and uses thereof
PH12017502390A1 (en) Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
SG10201914126RA (en) Anti-ox40 antibodies and their uses
SG10201803042PA (en) Anti-tim-3 antibodies
MX2018014227A (en) Single chain variable fragment cd3 binding proteins.
MY191581A (en) Anti-pd-1 antibodies
MX2019006043A (en) Prostate specific membrane antigen binding protein.
SG10201806108TA (en) Binding proteins and methods of use thereof
PH12017500406A1 (en) Novel anti-mfi2 antibodies and methods of use
MY207121A (en) Anti-ror antibody constructs
MX2018006249A (en) Novel anti-emr2 antibodies and methods of use.
PH12018500159A1 (en) Constructs targeting psa peptide/mhc complexes and uses thereof
MX2016004802A (en) Anti-rsp02 and/or anti-rsp03 antibodies and their uses.
MX2019011624A (en) Methods and compositions for reduction of immunogenicity.
MX2020003219A (en) Antibodies having specificity for btn2 and uses thereof.